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Abstract
Background: Adhesion molecules play an important role in the development and progression of coronary
atherosclerosis. The aim of this study was comparing the effect of Cratagol herbal tablet, aerobic exercise and
their combination on the serum levels of Intercellular adhesion molecule (ICAM)-1 and E-Selectin in patients
with stable angina pectoris.
Methods: Eighty stable angina pectoris patients aged between 45 and 65 years, were randomly divided into
four groups including three experimental groups and one control group: aerobic exercise (E), Crataegus
oxyacantha extract (S), aerobic exercise and Crataegus oxyacantha extract (S+E), and control (C). Blood sampling
was taken 24 h before and after 12 weeks of aerobic exercise and Crataegus oxyacantha extract consumption.
The results of serum levels of ICAM-1 and E-selectin were compared.
Results: Intergroup comparison of the data revealed a significant reduction (P <0.01) in serum levels of ICAM-1
and E-selectin in experimental groups. Analysis of data showed that the serum levels of ICAM-1 had significant
difference when group S+E was compared with groups S and C, but not group E (P = 0.021, P = 0.000 and P = 0.068,
respectively). Also the difference between the levels of E-selectin was significant comparing S+E and S but not E with
group C (P = 0.021, P = 0.000 and P = 0.052, respectively).
Conclusions: Twelve weeks effects of aerobic exercise and Crataegus oxyacantha extract consuming is an effective
complementary strategy to significantly lower the risk of atherosclerosis and heart problems.
Keywords: Aerobic exercise, Cratagol, ICM-1, E-selectin, Stable angina pectoris
Background
Stable angina pectoris is a type of ischemic heart disease
described by the discomfort (pain rarely called) in the
depth of the chest which has no specific location [1].
The heart coronary inflammation and atherosclerosis are
the main causes of chest angina [2, 3]. As mediating
agents during different stages of the atherosclerosis,
adhesion molecules play important roles in leukocyte
recruitment to the surface of vascular endothelium espe-
cially in the earlier stages of atherosclerosis. In addition,
in atherosclerosis region the leukocyte recruitment on
the endothelial cell surface is performed by Cell adhe-
sion molecules (CAMs). As a result, inflammatory
agents and adhesion molecules can cause insufficient
blood circulation in myocardial tissue and the lack of
oxygen leads to the disintegration of these tissues result-
ing in unstable improper performance of biochemical,
mechanical and electrical activities of myocardium. Thus
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eliminating or reducing of these agents can increase
the availability of oxygen to tissues and may help to re-
duce the heart problems. Among the adhesion cells
that have been proved their role in cardiovascular dis-
ease especially in atherosclerosis, are Intercellular
adhesion molecule (ICAM)-1, Vascular cell adhesion
molecule (VCAM)-1 and E-selectin [4, 5]. Intercellular
adhesion molecules (ICAMs) are cell surface glycopro-
teins that in inflammatory condition expressed on a
wide variety of cell types including leukocytes, epithe-
lial cells, endothelial cells and fibroblasts while, they
are low-expressed in the normal conditions in the vas-
cular endothelial cells, lymphocytes, and monocyte [6].
The demonstration of soluble E-selectin in blood can
thus be considered as conclusive evidence of endothelial
activation. E-selectin facilitates the earlier stages of poly-
morphonuclear adhesion to the endothelial cell, consti-
tuting an early serum marker of the inflammatory
response and promoting cellular damage by ischemia
[7]. In the prevention and treatment decade, more atten-
tion has been focused on the role of inflammatory
factors in the development of atherosclerosis [8]. There-
fore the chemical drugs such as non-steroidal anti-
inflammatory drugs (NSAIDs) have been used frequently
for management of this condition. The meta-analysis of
these non-steroidal anti-inflammatory drugs has showed
their strong relation with the risk of myocardial infarc-
tion, shock and heart stroke [9]. Among the common
anti-inflammatory drugs herbal medicines are well known.
Several botanicals including Crataegus oxyacantha extract
has been shown to play a role in the improve of cardiovas-
cular diseases such as hypertension, hyperlipidemia, and
in particular, congestive heart failure [10–13]. In this
regard, it was found that these effects may in part be due
to the presence of antioxidant flavonoid components
[1, 12]. According to conducted researches in attempt
to discover new ways to reduce these diseases, it seems
that Crataegus oxyacantha extract can be effective to
reduce inflammatory adhesion molecules such as ICAM-1
and E-selectin that are new indicators in the development
and progression of cardiovascular disease.
Aerobic training can caused reduction in serum levels
of ICAM-1 and E-selectin, too [14]. However, the
changes in serum levels of CAM-1 and E-selectin in
response to aerobic exercise reported conflictingly in
various research findings [15–18]. Nevertheless, as far
as we know, there is no report on the effect of Cratae-
gus on plasma inflammatory factor and adhesion
molecule levels. Walker et al. and Yuen et al. [19, 20]
studied the effect of aerobic exercise in interaction with
plant Crataegus, but in these studies only the favorable
effects on blood pressure, asthma, and enhanced exer-
cise capacity after consumption of herbal Crataegus
were reported.
The probable effect of herbal remedy in combination
with physical activity is the method, which can be consid-
ered to be special. Because of the importance of this issue,
this study was aimed to focus on anti-inflammatory effects
of Crataegus oxyacantha extract and aerobic training in
patients with stable angina to determine how efficient are
these methods, and to focus on the effect of Crataegus
oxyacantha extract for the first time in combination with
aerobic exercise on serum ICAM-1 and E-selectin.
Methods
Crataegus oxyacantha extract
Patients were given the Crataegus oxyacantha extract in
Cratagol tablets form. Cratagol was produced at Goldaru
pharmaceutical company (Isfahan, Iran) as a Coated tablets
in packs of 30 tablets containing 240 mg of dried extract of
Crataegus (Hawthorn) leaves and flowers that had been
standardized as 4–6 mg Vitexin-2- ramnozide per each
tablet. Crataegus oxyacantha extract in Cratagol tablets
was produced at EPO Istituto Farmochimico Fltoterapico
S.r.l. company (20141 Milano, Italy) (Additional file 1:
Appendix A. Supplementary Information). Also Cratagol
tablets containing adjuvants Avicel, corn starch, talc, mag-
nesium stearate and Arvzyl. In addition, the researchers
had no organizational or financial dependence to the com-
pany manufacturing crataegus extract.
Placebo tablets
Placebo tablets were prepared from Goldaru pharma-
ceutical company (Isfahan, Iran). The placebo was
prepared from granulated of inert powder of lactose and
the core of pressed tablets was coated similar to that of
Cratagol and the produced tablets were entirely similar
to the original product in terms of color, size and
appearance. The tablets were encoded and they were
used in clinical studies through the Double Blind
Method. Original and placebo tablets were previously
coded and after the required experiments the type of
drugs based on their codes in studied subjects were
determined, then statistical analysis were performed.
Expriments
Subjects were included patients with stable angina who
were under treatment at the Imam Ali cardioligy sub-
specialty polyclinic of Shahrekord, Iran. The diagnosis of
stable angina pectoris in the patients was performed by
Professor of Cardiology with coronary angiography test.
Patients whose angiography test history was carried out
between 1 and 12 months ago and there were no new
symptoms of pain or discomfort during this period and
also their coronary atherosclerosis was less than 50 %,
with clear treatment history within past 3 months, aged
between 45 and 65 years were selected for this study.
1500 potential cases of stable angina patients who were
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under treatment at the Imam Ali cardioligy sub-specialty
polyclinic of Shahrekord, Iran were investigated. Most of
these patients were out of our entrance requirements,
also unwillingness to participate the study, severe heart
failure, lack of accessibility, pharmacological interven-
tions and death were of the criteria for which the partici-
pants were eliminated and also patients with severe
heart failure and/or treated with digoxin, cisapride, anti-
coagulant, anti-arrhythmic drugs were excluded. Finally,
80 patients (44 male and 36 female) suffering from
ischemic heart disease of stable angina were recruited
and randomly assigned into four groups (20 patients
(11 male and 9 female)): three experimental groups
including aerobic exercise and placebo (E), Crataegus
oxyacantha extract (S), aerobic exercise and Crataegus
oxyacantha extract (S + E) and one control group (C)
and were followed for 12 weeks. Patients in each group
were homogenate with regards to age, sex, weight, and
Body Mass Index (BMI). Because of the relationship
between individual characteristics such as sex, age,
BMI, and weight and inflammatory markers measured
in this study, we attract the reviewer’s attention to the
fact that the researchers tried to reduce bias in the
results by choosing four homogenated groups. In par-
ticular, in order to excluding the effect of sex on the
results, the number of males and females were equal in
both groups, however, the distribution of men and
women based on their number was accidental. Random
number tables were used where each value was randomly
selected with an equal chance of choosing any integer
among 1–44 (men) and 45–80 (women) by QuickCalcs
online calculator (http://www.graphpad.com/quickcalcs/
randomn2.cfm) (Additional file 2: Table S1 and S2), which
allocated the numbers randomly to control and experi-
mental groups. Also, the amount of physical activity,
nutrition, diet, smoking, alcohol, symptoms and duration
of angina were accurately determined through medical
record questionnaires and reports contained in patient
records. As well as, we had no crossover or contamination
between groups and the current study was carried out as
multiple parallel groups until the end of experiments. The
patients in all 4 groups were administered with Methoral
(50 mg/day), Aspirin (80 mg/day), and sublingual Nitro-
glycerin in case of discomfort. Crataegus oxyacantha
extract were additionally taken by patients in the experi-
mental groups (S) and (S+E), twice a day, and each time
one tablet along with chemical medication with a little
water before meals. The control group (C) did not take
any Crataegus oxyacantha extract. The control group in
this study was not influenced by any intervention and also
did not receive the placebo tablets, but during the experi-
mental period, the weekly report of their nutritional status
and physical activity were recorded and were under con-
trol. This project was approved by the ethics committee of
the Medical University of Shahrekord, Iran and was
recorded in the clinical trial center with registration num-
ber IRCT201303098435N1. The participants had suffi-
cient information and awareness to participate in the
study and the process by which they filled out the consent
form was controlled and documented (Fig. 1).
Exercise program
Aerobic exercise program was performed on a treadmill
(after one week pre-adaptation) with an intensity of
40–60 % of heart rate reserve (HRR) and a rating of
perceived exertion (RPE) of 11–13 (on 6–20 Borg
scale), twice a week, each time 20–30 min, for 3 month
(12 week) [21]. Meanwhile, The patient’s conditions and
emotions, intensity and duration of exercise, blood
pressure, resting and exercise heart rate were controlled
at the beginning, during, and after exercise by digital
stethoscope (Geratherm Medical AG, German) and re-
corded. The exercise was stopped in case of discomfort
in the chest, asthma, dizziness, fatigue and loss of sys-
tolic blood pressure more than 10 mm Hg and the
exercises were continued, modified or interrupted under
the opinion of psychiatrists. The data obtained from exer-
cise and blood tests were collectively recorded in separate
sheets for final analysis. Training exercise was carried out
by specialized expert, under the direction of Professor of
Cardiology in the Imam Ali sub-specialty polyclinic of
Shahrekord, Iran.
Blood tests
Fasting blood test was performed 24 h before study and
also after 12 weeks. Blood tests were performed in
specialized laboratories from 5 ml blood sample of arm
vein of each patient. After 5 min of coagulation time, the
samples were centrifuged at 3000 rpm for 10 min.
Immediately blood tests were performed to determine
the levels of ICAM-1 and E-Selectin in serum using a
detection kit in specialized laboratories.
Measurements
Serum concentrations of ICAM-1, and E-selectin were
carried out using standard ELISA Kit (Boster, USA), with
a sensitivity of 10 pg/ml and 4 pg/ml respectively. An
ELISA reader (Ststfax 2100, USA) was also used.
Statistical analysis
Data were analyzed using SPSS 17 and the results presented
as mean ± standard deviation. Comparisons between groups
were made using the Kolmogorov-Smirnov test as well as
ANOVA followed by Least significant difference (LSD)
test. A two-sided P-value of 0.05 was considered as statis-
tically significant.
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Results
The data were classified according to average and stand-
ard deviation in intervention and control groups. The
Kolmogorov-Smirnov test showed normal distribution of
data in all stages of pre-test and post-test. Statical ana-
lysis showed that there were not any significant baseline
difference in serum levels of ICAM-1 between groups
(F = 0.28, P = 0.834). Also, there were not any significant
baseline difference in the levels of E-selectin between
groups (F = 0.97, P = 0.411).
The result of descriptive data for inflammatory factors
mean difference in each group, as well as the result of
t- test related to control and experimental groups
between pre-test and post-test are presented in Table 1.
A significant decline (p <0.01) was observed in the
mean difference between pre-test and post-test in all three
experimental groups including aerobic exercise (E),
Crataegus oxyacantha extract (S), combination of aerobic
exercise and consumption of Crataegus oxyacantha
extract (S+E) in the levels of ICAM-1 and E-selectin, while
in the control group the decrease due to intake of
chemical drugs did not show any significant difference
(ICAM-1, P = 0.412 , E-selectin, P = 0.313) (Table 1).
Statical Analysis of data showed a significant differ-
ence in serum levels of ICAM-1 in experimental groups
(F = 5.91, P = 0.002). Post hoc test showed that the
serum levels of ICAM-1 had significant difference when
group S + E was compared with groups S and C, but not
group E (P = 0.021, P = 0.000 and P = 0.068, respectively).
Also, significant differences in the levels of E-selectin was
observed among experimental groups (F = 3.34, P = 0.023).
Post hoc test showed that the difference between the
levels of E-selectin was significant comparing S+E
and S but not E with group C (P = 0.021, P = 0.000
and P = 0.052, respectively).
According to the weekly reports of patients’ condition
during the study (12 weeks) there was not seen any side
effects and evaluation of this case is out of our duty.
Discussion
The purpose of this study was comparing the effect of
Crataegus oxyacantha extract consumption, aerobic exer-
cise or their combination on the serum levels of ICAM-1
and E-Selectin in patients with stable angina pectoris.
One of the important finding of the present study was
the reduction in serum levels of ICAM-1 and E-Selectin
due to aerobic exercise. The changes in serum levels of
Fig. 1 Flow diagram of the trial
Table 1 Descriptive data t-test between pre-test and post-tes
Variables Group(n = 20) Means ± SD P
Pre-test Post-test
ICAM-1(ng/ml) E 65.5 ± 39.7 20.8 ± 2.7 0.001
S 61.3 ± 38.1 23.1 ± 3.7 0.001
S+E 90 ± 53.5 21.9 ± 3.9 0.001
C 56.1 ± 36 42.1 ± 33.1 0.412
E-selectin(ng/ml) E 3.2 ± 1.5 1.8 ± 1 0.001
S 3.4 ± 1.9 2.2 ± 1.3 0.003
S+E 3.5 ± 1.3 1.8 ± 0.7 0.001
C 2.7 ± 1.3 2.4 ± 1.2 0.313
Aerobic exercise ((E), n = 20, 11 males, 9 female), Crataegus oxyacantha extract
((S), n = 20, 11 males, 9 female), Aerobic exercise and Crataegus oxyacantha
extract supplements ((S + E), n = 20, 11 males, 9 female), Control ((C), n = 20, 11
males, 9 female), significant (P <0.05) in all groups except control (C)
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ICAM-1 and E-selectin in response to aerobic exercise
reported conflictingly in various research findings but
Studies have shown that ICAM-1 and E-selectin have a
similar relationship [15–17, 22–24]. Much evidence
suggests that inflammation plays important role in the
process of atherosclerosis [16]. During inflammation
process, cytokines such as TNF-a, IL-1B, IL-6, IL-10, IL-
1ra, sTNF-R are produced and activated at the site of
inflammation [8]. In the adhesion step, when leukocytes
are approaching the side of endothelial cells, molecules
such as VCAM- and ICAM-1 [25] and E-selectin [26]
accumulated. Changes in adhesion molecules such as
ICAM-1 and E-Selectin are closely related to leukocyte
accumulation and inflammatory factors C-reactive pro-
tein (CRP), Interleukin (IL)-6, Tumor necrosis factor
(TNF)-a, and Creatine kinase (CK). So the activity of
endothelial injuring markers is influenced by inflamma-
tory factors [15]. The increased expression of ICAM-1 is
dependent on nuclear factor-kappa B (NF-KB) And the
increased level of cytokines particularly Interleukin-1
beta (IL-1B), is responsible for the production of E-
selectin [6, 7, 27]. Studies showed that physical activity
can reduce the resting levels of these cytokines by redu-
cing obesity, leptin and increasing the adiponectin and
insulin sensitivity [16, 28–30]. Exercise training can
effect on adhesion molecules and endothelial injuring
markers by decreasing of inflammatory factors particu-
larly NF-KB and IL-1B [22, 31].
One of the most important finding of this study was the
reduction in the serum levels of ICAM-1 and E-selectin
after taking Crataegus oxyacantha extract. Crataegus
extract via its protective effect against oxidative stress
caused by released free radicals, which in turn it can
improve cardiac function and reduce infarct size in a rat
model of prolonged coronary ischemia and reperfusion
[10]. Chen et al. [32] stated that Crataegus improved
endothelial function so exposed anti hypertension proper-
ties. Crataegus stabilizes collagen function trough preven-
tion of its degradation by secreted enzymes from
leukocytes during inflammation, so the adverse effect of
atherosclerotic plaques and produced endothelial injury
markers on vessels can be prevented. it also inhibit the
action of free radicals so improves coronary artery dilation
and blood supply to the heart muscle via prevention
the activity of phosphodiesterase-Cyclic adenosine
mono-phosphate enzyme resulting in increase of cyclic
Adenosine monophosphate (AMP) in myocardium and
increase of its contractile strength. It increases the
time of excitability of heart muscle by blocking potas-
sium channels, which ultimately will lead to improved
arrhythmia [33, 34].
Of the other important finding in this study was the
reduction in serum levels of ICAM-1 and E-Selectin due
to aerobic exercise along with Crataegus oxyacantha
extract consumption. Walker et al. [19] were examined
the promising hypotensive effect of Crataegus extracts.
In this study, the blood pressure values at rest, after
exercise and after a stress test were evaluated which
both of systolic and diastolic blood pressure decreased
in all experimental groups. In addition, the desire to
reduce anxiety in those who had received Crataegus was
seen compared to the other groups [19]. Crataegus
extract in comparison with placebo increased the exer-
cise tolerance in the congestive heart failure. Since the
patients during the treatment period were not exposed
to any other cardio-active drug, it was proved that
advancing in exercise tolerance was due to the action of
the Crataegus extract [20]. Exercise program improves
environmental inflammatory markers associated with
endothelial dysfunction such as soluble intercellular
adhesion molecules and vascular, colony factor stimu-
lating of granulocyte and macrophage and chemo at-
tractant protein 1 by increasing of available nitro oxide
[16, 27, 35]. Because of its anti-hypertension property,
Crataegus can help to improve endothelial function and
to reduce the production of inflammatory markers and
adhesion molecules through inducing endothelium-
dependent no-mediated vasorelaxation by eNOS phos-
phorylation [12, 32, 36]. Physical activity decreased the
oxidative stress by modifying the anti-oxidative de-
fenses in serum [37–39]. In addition, the prescription
of Crataegus extract through its protective effect
against oxidative stress can result in improvement of
cardiac function [10, 40, 41]. Endurance activities and
reduction in carbohydrate storage of the body increase
the epinephrine, norepinephrine, the growth hormone,
and cortisol by the endocrine system, resulting in
increase of lipid oxidation [42], While the other part of
the beneficial effects of Crataegus can be considered for
reduction of lipid peroxidation and oxidative stress in
vascular tissue [10, 40, 43]. Since adipose tissue is one
of the main locations of secretion the inflammatory
markers and cytokines, endurance exercise in combin-
ation with Crataegus consumption increases lipolysis
rate and decreases the body fat, so it can be considered
as an effective strategy to reduce inflammatory media-
tors and cell adhesion molecules [11, 44]. This may
explain the observed stronger effect in the combination
group (S+E). Therefore in this study, the exercise along
with consumption of Crataegus oxyacantha extract
resulted in double reducing of plasma ICAM-1 and E-
selectin. While we could not fully control diet, rest, ex-
ercise and mental stress outside the clinic environment.
Conclusion
Our findings suggest that aerobic exercise and Crataegus
oxyacantha extract over a period of 12 weeks signifi-
cantly reducing of plasma Cell adhesion molecules in
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patients with stable angina pectoris. However, since aerobic
exercise and herbal drug induces many physiological pro-
cesses in the body, evaluation of the interaction between
aerobic exercise and herbal drug effects in patients with
heart disease needs further study.
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